Kimura Chemical Plants Co., Ltd. (6378.T) Stock Analysis
Kimura Chemical Plants combines a debt-free balance sheet, sticky maintenance revenue, nuclear and GX exposure, and roughly 10x TTM earnings for a potentially undervalued niche-industrial investment.
Overview
Kimura Chemical Plants is a century-old Japanese industrial specialist focused on custom chemical-process engineering, complex separation machinery, and nuclear lifecycle support. It serves domestic chemical, pharmaceutical, environmental, and utility customers through a combination of cyclical plant and equipment projects and higher-margin inspections, turnarounds, maintenance, and replacement work. Its moat rests on high switching costs, decades of thermodynamic and fluid-dynamics data, pilot-testing capability, nuclear-grade quality systems, and scarce titanium and zirconium welding expertise. **Q1 FY2027 showed a sharp earnings inflection:** revenue declined 6.0% year over year to ¥5.84 billion, but operating profit rose 164.5% to ¥523 million, net profit rose 169.8% to ¥370 million, and orders increased 62.2% to ¥9.10 billion. Management maintained FY2027 guidance for ¥24.80 billion revenue, ¥2.60 billion operating profit, ¥1.90 billion net profit, and a ¥41 dividend. **Valuation remains modest at approximately 10.1x TTM P/E, 1.14x P/B, and 4.85x EV/EBITDA**, despite 15.74% ROE and a 64.5% equity ratio. GX, nuclear decommissioning, and possible capital-efficiency improvements are near-term and long-term catalysts, but labor shortages and project execution risk temper the outlook.